About This Course
This is a distance learning online course, module code MSE:4087.
The course will start on 3 February 2025 in Semester 2, of the 2024-2025 academic year.
Who is this course for?
This module is aimed at healthcare professionals with responsibility for patients' medicines, including, doctors, pharmacists, nurses and independent prescribers from other professions.
Why study this course?
This module aims to empower healthcare professionals with an ability to provide better, more personalised care, which in turn will improve health outcomes for patients. It will prepare you for the imminent mainstreaming of pharmacogenomics.
It aims to develop background understanding about the latest developments in the science and applications of pharmacogenomics and stratified health care. You will gain an understanding of the general concepts of how genetic variation can affect the pharmacokinetics and pharmacodynamics of a drug, or cause immune-mediated adverse reactions. The module will use examples of pharmacogenomic tests that are relevant to clinical practice.
How long does this course take to complete?
The course is spread over 16 weeks. 22 hours of lectures will be released over the first 9 weeks. Weeks 10, 11, 13, 14 and 15 are for self-directed learning and preparation for the assessments in weeks 12 and 16.
Tutor
Professor
Dyfrig is Professor of Pharmacoeconomics, co-director of the Centre for Health Economics and Medicines Evaluation at 全民彩票 and Director of Research for the North Wales Medical School. He is also academic lead for Pharmacy at the Betsi Cadwaladr University Health Board (covering North Wales), and is honorary professor at the Department of Pharmacology and Thera